Boston Bio Systems Ltd — Board Meeting, 14-08-2025: Board Meeting

Boston Bio Systems' board meeting approved the financial results for the quarter ended June 30, 2025, reporting a profit after tax of 0.04 Cr and basic earnings per share of Rs 0.06. The board also appointed Mr. Shashank Kumar as the Secretarial Auditor and Mr. Nishant Sharma as the Internal Auditor for the financial year 2024-25. A key decision was the proposed change of the company's name from "Boston Bio Systems Limited" to "Boston Commerce Limited," subject to regulatory and shareholder approvals. This name change could signal a strategic re-alignment or broader business ventures for the company, impacting its long-term market perception.